CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12–17 Years, With First Episode Psychosis

导出原文传递

翻译打印收藏纠错

作者： Ditte,Rud? ^[1] ; Karsten Gjessing,Jensen ^[2] ; Marie Stentebjerg,Decara ^[3] ; Dea Gowers,Klauber ^[4] ; Birgitte,Fagerlund ^[5] ; Jens Richardt,M?llegaard ^[6] ; Kristian,Linnet ; Thomas,Werge ; Christoph U.,Correll ; Anders,Fink-Jensen ; Gesche,Jürgens ; Anne Katrine,Pagsberg

作者单位： Psychiatric Centre Copenhagen, University Hospital Copenhagen ^[1] Institute of Biological Psychiatry, Mental Health Center Sct. Hans, Roskilde, Denmark ^[2] From the Centre for Child and Adolescent Mental Health, Mental Health Services, Capital Region of ^[3] Lundbeck Foundation Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research ^[4] Section of Forensic Chemistry, Department of Forensic Medicine, University of Copenhagen, Copenhagen ^[5] Clinical Unit of Pharmacology, Zealand University Hospital, Roskilde, Denmark. ^[6]

发布时间 2022-03-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of clinical psychopharmacology

2021年41卷6期

667-672页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12–17 Years, With First Episode Psychosis

Journal of clinical psychopharmacology

相似文献

Journal of clinical psychopharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12–17 Years, With First Episode Psychosis

Journal of clinical psychopharmacology

相似文献

Journal of clinical psychopharmacology

相关期刊

检索历史清除